Skip to main content
Advertisement
  • Loading metrics

PrEP uptake and persistence amongst HIV-negative women who exchange sex for money or commodities in Kampala, Uganda: A qualitative inquiry assessing the influence of pregnancy

  • Shivali Joshi,

    Roles Formal analysis, Methodology, Writing – original draft

    Affiliation Institute for Global Health Sciences, University of California, San Francisco, (UCSF), San Francisco, California, United States of America

  • Catherine Namuddu,

    Roles Investigation, Project administration, Validation, Writing – review & editing

    Affiliation Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebbe, Uganda

  • Francis Xavier Kasujja,

    Roles Project administration, Supervision, Writing – review & editing

    Affiliation Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebbe, Uganda

  • Miriam Mirembe,

    Roles Investigation, Project administration, Supervision, Writing – review & editing

    Affiliation Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebbe, Uganda

  • Jaco Homsy,

    Roles Conceptualization, Funding acquisition, Writing – review & editing

    Affiliation Institute for Global Health Sciences, University of California, San Francisco, (UCSF), San Francisco, California, United States of America

  • Janet Seeley,

    Roles Conceptualization, Writing – review & editing

    Affiliations Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebbe, Uganda, Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom

  • Rachel King

    Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Rachel.King@ucsf.edu

    Affiliation Institute for Global Health Sciences, University of California, San Francisco, (UCSF), San Francisco, California, United States of America

Abstract

Pregnant young women who exchange sex for money or commodities are at elevated biological and social risk for HIV acquisition. PrEP serves as an effective means of HIV prevention, including during pregnancy. This study aimed to explore attitudes, experiences and challenges with PrEP to understand what motivates or limits PrEP uptake and adherence specifically during pregnancy among this population of young women. Semi-structured interviews were conducted with 23 participants, recruited from the Prevention on PrEP (POPPi) study in the Good Health for Women Project clinic in Kampala, Uganda. POPPi’s inclusion criteria comprised of HIV-uninfected women, aged 15–24, who exchange sex for money or commodities. Interviews focused on experience with PrEP and pregnancy. Data were analyzed utilizing a framework analysis approach. Key themes were comprised of participant barriers to and facilitators of PrEP uptake and adherence. Reasons for PrEP initiation included desire for autonomy and agency, mistrust of partners, and social support. Participants expressed challenges with initiating or sustaining their use of PrEP, including pregnancy, PrEP access and perceived or felt stigma. During pregnancy, participants’ primary motivators for altering PrEP use were either understanding of PrEP safety for their baby or changes in perceptions of their HIV risk. Many of these factors were similar across participants who had experience with pregnancy and those who did not. This study highlights the importance of addressing barriers to and facilitators of PrEP uptake and persistence, especially during pregnancy where risk is elevated, with a multi-level approach. Community-oriented education, stigma reduction activities alongside access to PrEP, can serve as means for adherence. The development of robust PrEP support services and guidelines regarding PrEP use during pregnancy among high-risk women, and strategies for their implementation, are of utmost importance for the control of HIV in key populations and the elimination of mother-to-child transmission of HIV.

Introduction

There have been substantial advances in HIV testing and treatment globally. However, despite these gains, there were 1.7 million new HIV infections worldwide in 2019 before the global COVID pandemic, of which almost 60% occurred in sub-Saharan Africa [1].

The Joint United Nations Programme on HIV/AIDS defines transactional sex as “a non-marital, non-commercial sexual relationship motivated by an implicit assumption that sex will be exchanged for material support or other benefits” [2, 3]. Transactional sex is different from formal sex work as the relationship or exchange between individuals may not be formally established; it is inclusive of relationships with shared emotional intimacy as well as exchanges of money and goods for sex [2]. In the case of formal sex work, sex is explicitly suggested as a commercial commodity. Much social research on HIV has not included women who engage in sex work of all kinds, often due to a lack of categorization of transactional sex practices. Thus, data regarding female sex workers (FSWs), a commonly used classification, often underestimates the number of women who engage in similar sexual behaviors [1]. Here we refer to both formal sex workers and women who engage in transactional sex, as young women who exchange sex for money or commodities (YWES).

In Uganda, women who engage in both transactional and non-transactional sex, often driven by poverty, have one of the highest risks for HIV acquisition. This is the case even in comparison to other high-risk groups including men who have sex with men, injection drug users, and prisoners [4]. HIV prevalence amongst FSWs is close to 33% [4, 5]. FSW in Uganda reside mostly in urban centers as well as some rural regions of the country. Because sex work is illegal in Uganda, they must operate amongst informal sectors of society [6]. FSWs, can be prosecuted and incarcerated even without strong evidence [6]. As a result, they face a number of challenges to well-being relating to criminalization, violence, mobility, stigma, and other abuse [7]. Legal barriers, along with cultural and religious constraints, perpetuate stigma and social isolation. Thus, navigation of reproductive and sexual health resources remains extremely difficult for FSW in Uganda.

While these vulnerabilities are true for high-risk women of all ages, the vulnerability of young women is heightened. Young women new to sex work are at higher risk for contracting HIV and other sexually transmitted infections (STIs) [8]. Biologically, younger women possess an increased risk for trauma upon sexual contact compared to older women. There are some possible explanations from Dellar et al (2015) such as an immature cervix with the exposure of a higher proportion of genital mucosa with high levels of genital inflammation [9]. Behaviorally, higher incidence of drug use has been associated with YWES [8]. Socially and culturally, societal pressures are harder to navigate for younger, less powerful members of society [9]. Additionally, due to the illegality of sex work in Uganda, YWES are forced to work and live in areas of cities that are least equipped with adequate health resources [8]. As a result, HIV prevention services for YWES are limited, and there is a need for interventions that address the specific sociopolitical and cultural barriers that affect this population.

The Prevention on Pre-exposure Prophylaxis (POPPi), the parent study of this sub-study, has examined YWES in Uganda amongst their social and sexual networks [10]. POPPi aimed to empower YWES with effective HIV prevention tools that they were able to control and administer themselves, namely Pre-exposure Prophylaxis (PrEP) and HIV oral fluid self-tests [11]. The study focused on this young population to both intervene early, before women are infected, and provide services to a group that maybe overlooked or have difficulty accessing healthcare.

Little research has been conducted on adherence to PrEP once YWES become pregnant. Addressing uptake and adherence among such women is of critical concern because many YWES continue to work during early stages of pregnancy to make money before they are no longer able to work. In addition, pregnancy itself is a vulnerable time for contracting HIV as it causes biological changes, including alterations in levels of progesterone and estrogen and the vaginal environment, which are known risk factors for HIV infection [12, 13]. Additionally, pregnancy modifies innate and adaptive immunity, creating a lowered immune response throughout pregnancy. Contracting HIV during pregnancy also increases risk for maternal-to-child transmission; thus, understanding the determinants of HIV prevention and PrEP adherence during pregnancy is critical for both pregnant YWES mothers and their children [13].

The WHO acknowledges concerns regarding PrEP and potential adverse birth outcomes, however strongly recommends Tenofovir-based PrEP for pregnant, high-risk populations [14]. There is consensus that the risks of contracting HIV during pregnancy, birth and breastfeeding far outweigh the largely unknown risks of PrEP use [15]. There are a number of social, personal, policy and health-systems barriers that affect the way PrEP is used prior to and during pregnancy. These barriers can create uncertainty regarding the safety of PrEP for pregnant women, as this information is often not readily available to the public and/or enforced within health facilities and care protocols [15]. Social level barriers surrounding PrEP stigma and misconceptions affect PrEP acceptance and access, as taking PrEP is often equated to taking antiretroviral medication when already infected with HIV. For populations who are wary of being exposed in terms of occupation or sexuality, this misconception makes it risky to be seen taking the pill [14]. Taking PrEP may also imply that one is actively engaging in sexual activity. As a result, taking PrEP for individuals in partnerships could suggest unfaithfulness and women more often than men may be accused of this [14]. At the policy and health system level, in the Ugandan national guidelines, PrEP was recommended for populations at increased risk of HIV acquisition, which meant that not everyone is eligible and not all facilities have access to the drugs [16]. Lastly, personal barriers, including education to assess the risks and benefits of taking PrEP and adhering to it while pregnant and breastfeeding, must be considered [14]. Thus, evaluation of the multi-level barriers of using PrEP during pregnancy and the postpartum period, is crucial to understanding attitudes towards PrEP and PrEP adherence among a high risk population. As part of the POPPi study, the present sub-study explored the way these barriers impact YWES in Uganda, along with general attitudes of YWES towards PrEP in hopes to understand what motivates PrEP adherence, or lack of, during pregnancy.

Materials and methods

The goal of the parent study, (POPPi) was to develop and assess an intervention to enhance initiation and adherence to PrEP among HIV negative Young Women at High Risk which began recruitment in February 2019 and completed a 12-month follow-up in 2020.

Ethics statement

All participants provided written informed consent and understanding was assessed using an ‘assessment of understanding form’. The informed consent form included goals of the study. We included some minors in this study (seven in total). As many young sex workers are actually orphans, in agreement with the Uganda National Council of Science and Technology (UNCST), all minors who fit with the definition of ‘emancipated minors’ were eligible to consent to research without their parents also consenting. The study was approved in Uganda by the Uganda Virus Research Institute Research and Ethics committee and the UNCST as well as the University of California, San Francisco (UCSF) IRBs. The trial was registered at clinical trials.gov (NCT04030520).

Parent study

In 2017, the study team mapped out hot spots and popular meeting points frequented by young women and high-risk youth in urban Kampala, the capital city of Uganda (population about 2.5 million). Anyone who tested HIV positive would not be eligible for study enrolment, but would be immediately offered ART at the study clinic. Anyone who tested STI positive would be eligible and offered treatment.

Phase 1 of POPPi consisted of conducting focus group discussions (FGDs) and interviewing participants to both understand the use of HIV prevention services and identify the overall feasibility and acceptability of the proposed behavioral intervention to improve uptake and adherence to PrEP. Focus groups were held with community members, YWES, key informants including health workers, male partners and opinion leaders, and peer educators, and interviews were specifically conducted with key-informants at the study clinic. Phase 2 of the parent study was a pilot randomized controlled trial (RCT) comparing POPPi intervention outcomes to the study clinic’s standard of care. This intervention consisted of group sessions on health empowerment, PrEP literacy, and social empowerment, along with individual counseling sessions on topics like HIV and STI transmission, and family planning. Phase 2, the RCT, included a 12-month follow-up, to evaluate PrEP uptake and adherence using self-report and a biomarker of PrEP drug levels in hair (results not available).

Sub-study design

This sub-study employed a qualitative methodology given the nature of the research question, which focused on informing elements such as health-seeking behavior, decision-making, and motivations that were best captured through a flexible form of data collection, specifically semi-structured interviews aimed to gather views on focused topics, while remaining open to accommodate new and emerging subjects and themes in a private and confidential manner.

The recruitment process and data collection started in February 2020; data collection continued through June 2020. Participants were taking part in the intervention sessions during the time of data collection for this sub-study. By the time of this sub-study, the participants were known by all study staff members including the interviewer who was trusted by the participants.

Study participant selection and recruitment

The study population of interest was the same as the parent study (POPPi): young women who engage in high-risk sexual activity as defined by the behavior that put them at risk of contracting HIV, other STIs, or getting pregnant, a definition that is used within the study clinic where other studies on this population were implemented. Pre-screening procedures to assess transactional sex included: verbal pre-screening before the screening form was administered where study staff would ask potential participants questions about their lives such as; how and where participants lived, how they earned a living. Some participants, who were recruited at night would be identified on the streets and in bars where it would be clear that they were practicing commercial or transactional sex. The clinic recruitment questions included:

Have you been on a fishing landing site in the past 3 months? Have you had an STI in the last 3 months? How many times do you have sex with different partners a day? How many irregular and regular sexual partners do you currently have? How many times do you use condoms with those different partners?

Women were recruited depending on response to these questions. Thus, women engaged in any sex for money or commodities were eligible for enrolment. Women for the main study were recruited mostly from bars and lodges in Kampala, and subsequently screened for HIV, hepatitis B, and creatinine levels. They were then enrolled in POPPi at the study clinic. For the purposes of this sub-study, potential participants were identified by the POPPi research team and contacted by phone.

For the sub-study, participant eligibility mirrored POPPi’s inclusion criteria, as follows: women aged 15–24 years currently enrolled in POPPi in Kampala, Uganda, testing HIV-antibody negative at enrolment in this study, having demonstrated understanding of POPPi study guidelines and scope, and providing oral and written consent. For the sub-study, eligible women were recruited into one of four categories to acquire relevant themes for data analysis: (1) PrEP-naive, (2) having started and stopped PrEP, (3) having started, stopped, and reinitiated PrEP, and (4) stable on PrEP, meaning that the participant had initiated PrEP and had continued with no lapses until the time of data collection. Of these, all women in the parent study who were currently pregnant or had previously been pregnant while enrolled in the study, were contacted first. Nulliparous women in the four PrEP categories mentioned above were listed and all contacted to provide a comparison to those who were previously or currently pregnant. No specific pregnancy duration or timeframe was used given the young age of participants implying any past pregnancy likely occurred fairly recently.

Data collection

After piloting the interview guide, interviews began in February 2020, during the follow-up period of the RCT, and were conducted by an experienced, female, social science interviewer, in Luganda either at the study clinic or at participants’ homes where there was a private space to conduct the interview with nobody else present. The interviewer has had over 30 years of experience conducting in-depth interviews with urban and rural women in the study setting. Participants were compensated 20,000 Uganda shillings (about US $6) for their time. Participants were identified solely by their study IDs; no identifiable data were recorded. De-identified data were securely stored on an encrypted device and audio recordings were deleted after transcription was completed.

A total of 23 interviews were conducted and analyzed to reach thematic saturation [17]. No participant who was asked to participate refused. Interviews took an average of 60 minutes, followed a semi-structured guide which contained an introduction to the study, asked participants for a brief background including their sexual and reproductive history and characteristics, and categorized specific questions and probes by modes of inquiry. The two major themes of inquiry that we addressed were around PrEP knowledge and experience and pregnancy. Specifically, participants were asked: experience with PrEP and PrEP and pregnancy, motivations to take PrEP, knowledge on the prevalence of PrEP use in the community, personal PrEP use and adherence during pregnancy, and types of care and support available while pregnant.

Data analysis.

Audio recordings of the interviews were uploaded onto a secure device, first transcribed in Luganda, and subsequently translated to English. A framework analysis approach was used for data analysis [18]. Framework analysis uses six steps to generate themes including: 1 –Transcription, 2 –Familiarization, 3—Developing a working analytical framework, 4—Applying the analytical framework, 5—Charting data into the framework with a spreadsheet to generate a matrix, 6—Interpreting the data with analytic memos that interrogate theoretical concepts or mapping connections between categories to explore relationships and/or causality. The analytical framework in this approach allowed the researchers to map and categorize data as well as find associations and ultimately derive conclusions [19]. Transcripts were uploaded to NVivo, a qualitative data analysis software, where they were coded. A codebook was developed using both emerging and a priori codes, defining each of the codes, both broader, thematic codes, and sub-codes that fell under the themes [18]. Coding was done first by the first author (SJ) then checked and discussed with the last author (RLK and study team). The entire study team apart from SJ was based in Uganda and all members are intimately familiar with the context. The codes were then re-applied to the transcripts in NVivo, with heightened scrutiny and attention. A framework analysis matrix was developed in Microsoft Excel using major themes as categories and summarizing each transcript by category. These summaries contained quotes, observations, and overall content summarization. Once the data was in the framework analysis matrix, it was interpreted and used to derive associations, interpretations and conclusions [18]. The preliminary findings were summarized and presented both to study staff members to ensure rigor and check validity and again to a selected group of study participants as a member-check for correct interpretation of results. We used the ‘Barriers to PrEP use’ framework adapted from Davies and Heffron to assist organizing the findings and the COREQ guidelines to ensure rigor (Fig 1) [20].

thumbnail
Fig 1. Participant’s account of barriers to and facilitators of PrEP use organized by policy, health systems, social, and personal levels.

Adapted from Davies and Heffron, 2018 [14].

https://doi.org/10.1371/journal.pgph.0000434.g001

Results

Participants

Almost half (48%) of the participants fell between the ages of 19–21 years, (Table 1). Most participants had left school, due to a lack of financial capability to continue education, either during Primary or Secondary school. Most participants declared themselves Roman Catholics or Muslims (30% and 22%).

thumbnail
Table 1. Sub study participants’ demographic characteristics, Kampala, Uganda.

https://doi.org/10.1371/journal.pgph.0000434.t001

In the parent study of total 60 participants, there were 23 intended and 39 unintended pregnancies overall (Table 2). There were 12 (39%) unintended pregnancies during three follow-up visits in the intervention arm and 19 (61%) in the control arm over a total of 31 pregnancies during the three, six and 12 follow-up month follow-up visits (Table 2).

thumbnail
Table 2. Self-reported pregnancy planning by study arm in parent study, Kampala, Uganda (Total parent study (N = 60).

https://doi.org/10.1371/journal.pgph.0000434.t002

With regards to sexual and reproductive history and characteristics, most participants had either one or no children. The majority had between one and nine different sexual partners within a one-month period (Table 3). When asked about condom use with spouses or partners they lived with and with paying customers within the past month, most participants said they never used male condoms with partners, while with paying customers the majority of participants sometimes used male condoms (Table 3). The two most common reasons for not using male condoms during sexual interactions with either partners or paying customers were: 1) sexual partners preferred sex without condoms, and 2) there were no condoms available. With regards to background context of study participants’ sexual behavior, some described how they were able to survive by selling sweets on the roadside or washing clothes to supplement their income.

thumbnail
Table 3. Sub study participants’ sexual and reproductive health characteristics, Kampala, Uganda.

https://doi.org/10.1371/journal.pgph.0000434.t003

Most participants reported not having used addictive substances in their lifetime, however, for those who did, the substances consumed were shisha (tobacco), mayirungi (khat), and cocaine (Table 3).

Participants were categorized based on PrEP status and parity. In the text we have identified participants based on age groups, under 20 and 20–24 years old as well as PrEP status. Most participants reported they were stable on PrEP (N = 16), three participants had never started PrEP at the time of the interviews, one had started and stopped, and three had started, stopped and reinitiated PrEP. Many participants had a pregnancy during their lifetime but, because they did not get pregnant during the course of the POPPi study, were excluded from the currently pregnant category. We determined five major themes around barriers to, and facilitators of adherence to PrEP: 1) agency and trust, 2) safety, PrEP and Pregnancy 3) HIV, sex work-related stigma and pregnancy, 4) social support and societal perceptions, and 5) access to PrEP and PrEP information especially while pregnant.

Agency and trust

Participants’ decisions to initiate PrEP and stay consistent on PrEP were influenced by their desires for autonomy over their sexual health and livelihood. One participant under 20 years old, who was stable on PrEP and pregnant at the time of the interview, expressed her preference for PrEP over other forms of HIV prevention, like condoms:

Because with PrEP, it’s you to control it, if you don’t swallow it, it’s you to get infected but for a condom, if it’s to burst, [you have no control over it].

She described a sentiment that multiple participants shared, that PrEP enabled a choice to protect one’s life. Thus, upon learning about PrEP, many were motivated to try it.

Many participants also expressed that mistrust in partners motivated them to take PrEP. Participants who did not trust their partner’s behavior, in terms of having multiple sexual partners, found PrEP to be a way to ensure their own health, while a few who were consistently with a partner they trusted, did not feel the need to take PrEP. One participant shared a conversation she had with her partner.

I explained to him the reason I was swallowing these pills [PrEP], but if he is serious that we are going to be together at home and he is not going to have partners outside our relationship I can stop them because even the basawo [doctors] told me that if a time comes and I get a serious partner and we are going to stay together it is your right to stop swallowing the pills”

(under 20 years old, stable on PrEP, previously pregnant).

This trust, or lack thereof, also extended to partners’ use of condoms. All participants reported experience having tried to use condoms regularly. Participants who were able to ask customers and regular partners to use condoms were less inclined to stay on PrEP. Those who were unable to ensure condom use during sexual interactions were more motivated to take PrEP. Additionally, a few participants also expressed trusting their partners enough not to use condoms. If this was the case, they were still able to use PrEP to maintain continuous protection. As expressed by one participant:

“There is only one guy I don’t use a condom with and that’s because when we first met, he told me we go to hospital and test together which we did, and we were both HIV negative. But I still take PrEP whether I’m meeting with this guy or with any other customer”

(under 20 years old, stable on PrEP, previously pregnant).

PrEP allowed women choices within their occupation as well as opportunities for future occupations. Some participants were motivated to take PrEP to stay healthy in the present, so that future work opportunities and pathways of life would remain open. When describing her conversations with other women, one participant shared,

"I tell them that we have to adhere to PrEP because we don’t know what’s ahead of us according to the kind of work we do. Let’s take our drugs because it’s for our own good, you never know in future we might decide to quit this work but it is good to quit when we are still negative and [able to] do other things”

(20–24 years old, stable on PrEP, never pregnant).

Safety, PrEP and pregnancy

Issues of safety related to personal security, PrEP safety, and occupational safety were the most commonly discussed reasons for initiating or stopping PrEP. Participants expressed PrEP’s ability to provide personal protection even when customers, partners, and society at large could not. In situations where condoms were not an option (customer tore them, refused to wear them, condoms were expired/burst, or not available), participants were still able to keep themselves physically safe.

Participants talked about the inability of society to keep YWES and the sex worker community safe. If participants were in a situation where force was used, or a customer refused to wear a condom, there was no one to turn to. Thus, it was their own responsibility to ensure their personal safety. Two participants shared these experiences,

At times you link up with a customer and you agree with him that you are going to use a condom and on reaching inside the room he insists he wants live [condomless] sex; when you make an alarm the outsiders laugh

(20–24 years old, stable on PrEP, previously pregnant).

“Me, I want condoms but what if he refuses and uses force on you?…Remember you’re at his place you have nowhere to report him. You also fear to say you were raped. Me, I fear”

(under 20 years old, stable on PrEP, never pregnant).

The safety or lack of safety of PrEP was a large determinant as to whether participants sought out PrEP and continued to take the drugs. Most participants were aware that PrEP was safe for pregnant women and their unborn babies; however, some participants believed that PrEP would harm the baby. This was the most common reason for not initiating PrEP amongst participants who had experience with pregnancy.

“When I was pregnant with this child I was told to take PrEP which I somehow feared but then I accepted to take it, reaching home I again feared and decided to take the pills back to the clinic and told the counselors I would take the pills after pregnancy because I feared that the pills might affect my unborn baby”

(20–24 years old, started, stopped, & re-initiated PrEP, previously pregnant).

One participant feared that taking PrEP during pregnancy would interfere with her high blood pressure, so she stopped. Another was not comfortable with the PrEP-related side effects she experienced during her pregnancy; she also took a break from the drugs. All participants who were on PrEP mentioned side effects as part of their experience with the medication, though in most cases, these effects did not deter participants from initiating or persisting on PrEP. Those who considered PrEP safe and trusted PrEP either had been tested for HIV after having condomless sex and were still HIV negative or had heard from friends that the drug was effective.

Another factor that led many participants to stop PrEP use was the safety of high-risk work while pregnant. Though some women who became pregnant continued to work for the first three to five months of pregnancy, there were many who stopped working due to the perceived and real danger of multiple sexual partners while pregnant. Because these women were not working, they stopped taking PrEP.

"We get customers who beat us up and kick us, I realized I would get complications and besides they say it’s not good to sleep with different men while pregnant. The child may get complications”

(20–24 years old, never started PrEP, currently pregnant).

HIV, sex work-related stigma and pregnancy

All 23 participants discussed their experiences with PrEP-related stigma. Because PrEP pills resemble HIV antiretrovirals (ARVs), participants shared that society understood that those who take PrEP are HIV positive, as most did not know the difference between PrEP and ARVs. Thus, the high-risk community on PrEP is stigmatized similarly to individuals who are HIV positive.

"I cannot talk to anyone about it [PrEP] because people have different views about the drug. Someone can show you they have understood and accepted yet in actual sense they have not bought the idea and even talk about you to other people telling them you are HIV positive"

(under 20 years old, stable on PrEP, never pregnant).

Most participants were unable to share that they were on PrEP with friends, family, and partners. In many cases, this did not deter participants from initiating PrEP; however, it made it challenging to stay consistent with PrEP. Some participants would take their pills in secret and lie to family and partners about the medication. One participant was going to stay with friends for a while and intentionally left her PrEP at home for fear of her friends finding the PrEP container.

"I thought they will think I am HIV infected because if someone knows you’re infected they can’t love you the same way as before"

(under 20 years old, stable on PrEP, never pregnant).

Stigma also played a role in dictating at what point participants had to stop working. A few participants spoke about personal or friends’ experiences working through the first few months of pregnancy but not being able to attract customers once the pregnancy was showing due to stigma, and thus not initiating or persisting taking PrEP because not sexually active.

“Once pregnant, we get off the streets… it’s because no one can buy a pregnant woman when he is seeing [another] one who is not [pregnant]”

(20–24 years old, stable on PrEP, never pregnant).

Participants spoke of instances regarding stigma in healthcare settings. Many participants went to government hospitals to access free antenatal care. Some descriptions of stigma related to sex work did not emerge as a major indicator of starting or stopping PrEP; however, a participant described the way in which this stigma could lead to difficulties with obtaining PrEP when a high-risk woman was pregnant.

"After getting pregnant those girls don’t want to go back where they were accessing PrEP from…There is a neighbor of mine who used to get her medicine from Mulago but when she became pregnant she did not go back”

(under 20 years old, stable on PrEP, previously pregnant).

Social support and societal perceptions

Participants described the role of social networks and societal perceptions in encouraging initiation into sex work, motivating PrEP use, and influencing community health and safety. Often, participants were recruited into sex work by their friends who noticed that participants were unhappy in their current occupations or without income and saw sex work as an economic opportunity. Thus, many participants followed their friends into sex work, often living together or with groups of women who all worked as sex workers together.

Information on PrEP and HIV prevention traveled through the high-risk community from individual to individual, influencing participant opinions and choices. These perceptions influenced participant behavior as some participants hid PrEP from their friends while others encouraged their fellow sex workers to join studies where they could access PrEP and care. Most participants were told about the POPPi study by other friends and continued to recruit friends throughout their time in the study. An under 20-year-old study participant, stable on PrEP and previously pregnant, described her experience with educating a friend about PrEP.

"A friend of mine was so worried that men will infect her with HIV because they don’t want to use condoms and she wanted to know where she could get PrEP, I showed her what the pills look like and told her to search around for them.

Although participant behavior regarding PrEP was influenced by societal perceptions, social networks did not seem to determine whether participants stopped or stayed consistent on PrEP.

Support for high-risk women, outside of smaller social networks, especially for pregnant women, was unknown to the participants. All participants stated they did not know of any organizations, individuals/communities, or systems for support for pregnant sex workers and high-risk women, aside from those offered at the study clinic. One participant, when asked how she supported herself while pregnant shared,

“Sometimes the father of this child would give me financial support. I would be patient and wait in case I used it up. I used to plan, stock food and used the rest to shop for the baby. Feeding was hard, I used not to eat food”

(20–24 years old, never started PrEP, previously pregnant).

Access to PrEP and PrEP information

As a part of the study clinic and the POPPi study, participants were given access to PrEP according to Uganda’s Ministry of Health guidelines. This allowed participants education on how to use PrEP, when to take it, and how to integrate it into one’s lifestyle. However, amongst larger communities of women engaging in sex work, participants stated that many did not know about the existence of PrEP.

"It’s not easy if the hospital has not informed you, however for us we got a chance that we have a clinic which informs us…When you look at our government have you ever heard it announce pills preventing HIV…All they do is to give out condoms and that’s why our clinic is a better option, it sensitizes you about new things"

(20-24-year-old, stable on PrEP, previously pregnant)

Along with lack of access to information on PrEP, a pregnant participant expressed that it is difficult for women to find PrEP in health facilities and physically access it.

“If PrEP is medicine for HIV/AIDs prevention, how come for us, in clinics and pharmacies, we don’t find it.” Often, women are unable to travel to go get the medication even if it is provided at government hospitals.

(20-24-year-old, stable on PrEP, currently pregnant)

One participant brought up the potential expense associated with the drug when asked if pregnant women have access to PrEP. While access to PrEP was not a barrier for participants in this study, they communicated that access to PrEP outside of the study would prevent women they knew from taking the medication which is particularly important while pregnant.

Discussion

This qualitative study, nested within the POPPi study, aimed to understand major barriers to, and facilitators of PrEP uptake and adherence amongst young, pregnant, previously pregnant and non-pregnant, high-risk women in Kampala, Uganda. Most common reasons for PrEP initiation included desire for autonomy and agency, trust and lack of trust of partners, social support, stigma, and societal perceptions of PrEP. Sex work stigma has been discussed in the literature and is highly pervasive, thus making PrEP an option for more discreet HIV prevention [21]. Participants expressed challenges with initiating or staying consistently on PrEP, which included being pregnant, PrEP access and stigma associated with PrEP use. During pregnancy specifically, participants’ primary motivators for altering PrEP use were either understanding and misunderstanding PrEP safety or changes in beliefs regarding their HIV risk. One study in South Africa among women pregnant and post-partum found that factors associated with discontinuation of PrEP included being post-partum, having more than one child and experiencing side effects [22]. In the literature, it has been noted that HIV is only one of the many concerns YWES face, and takes different priorities at different times, and participants in our study obviously had multiple and diverse highly challenging life situations including violence, food and housing insecurity, especially during COVID lockdowns [23]. In our study, participants, however, were highly cognizant that their health was quite important to their ability to make a living from sex and getting HIV could pose a problem. These findings were organized within the ‘Barriers to PrEP use’ framework adapted from Davies and Heffron, to demonstrate the interrelatedness of PrEP barriers and facilitators and understand them within the personal, societal health systems, and larger policy level actors (Fig 1) [14].

Personal level

At the personal level, participant motivations for and challenges with taking PrEP were largely dependent on the way PrEP made individuals feel. For many, the medication provided a feeling of personal protection and control over one’s body and health. Participants were less reliant on partners and customers, and their use of condoms, to ensure their protection from HIV.

PrEP also enabled participants to foresee a future in which they continued to be healthy enough to work and transition into opportunities other than sex work. Previous studies have described low PrEP uptake amongst young, mobile populations due to difficulties with adherence and low perception of risk [24]. Studies in other populations such gay and bisexual men and pregnant and postpartum women in South Africa had similar reasons of lower risk perception for discontinuation of PrEP [22, 25]. However, many participants in POPPi were aware of their vulnerability and high-risk circumstance, and thus, were eager to take PrEP. This may have, in part, been due to this study population’s exposure to HIV education, as lowered risk perception has been seen in populations with less robust HIV education [26].

Some participants who faced personal difficulties with staying on PrEP attributed these to the drug’s side effects. Among pregnant women in South Africa who initiated PrEP, about half experienced side effects of nausea and vomiting in the first month [22]. Among our participants, these side effects were not unexpected for most and did not deter participants from initiating PrEP, they created anxieties around taking the drugs along with disruptions in their schedules, causing their PrEP adherence to fluctuate. Many participants worked extremely late nights and early mornings, and thus, having to remember to take a pill daily at the same time proved difficult. Both experiences with side effects and challenges with PrEP logistics make a case for longer-acting PrEP formulations and adequate time to adjust to side effects [26]. Participants expressed anticipation of a form of PrEP that could be taken monthly, or every six months. The recent successful performance of injectable PrEP could drastically eliminate many of these barriers for high-risk communities [27, 28].

A woman’s risk of HIV acquisition doubles during pregnancy and breastfeeding [29]. Though this heightened risk was not a driver of changes in participant engagement in risky behaviors, participants’ understanding of their HIV risk changed throughout pregnancy. Because some participants were unable or unwilling to work throughout pregnancy, due to fear of harm directed at themselves and their child, many stopped taking PrEP. Others worked through the first three to five months of their pregnancies and would take PrEP while sexually active; these participants stopped PrEP when they stopped working. Either way, most were able to accurately identify their risk periods and adjusted their PrEP use accordingly. Understanding risk and perceptions of risk has been known to aid in PrEP consistency and uptake [30]. This feature, demonstrated by the participants, is likely also attributed to robust HIV education through the POPPi study.

Societal level

Social perceptions of PrEP were crucial in participants’ understanding of the medication and the way in which participants could take PrEP comfortably. Participants often learned about PrEP from their social networks and were either encouraged or discouraged to initiate the prophylaxis by peers. Social and peer support appeared to be critical to the process of accessing and adhering to PrEP, confirming what has been found in many vulnerable communities [31, 32].

Participants were challenged by both HIV and sex work-related stigma that pervaded society. Most participants said they hid their PrEP use from family, friends, and partners, for fear of being mistaken as an HIV-infected person taking ARV, thus making it difficult to stay consistent on the medication. Nevertheless, participants found creative ways to navigate stigma out of necessity and it did not seem to serve as a barrier for PrEP initiation or continuation.

Partner “buy-in” and trust were other important factors in shaping participants’ PrEP use. Previous studies explored the role of partner influence, often as a barrier to taking PrEP, a theme that emerged in this study as well [33]. In this study, partners directly influenced participants perceptions of the drug itself, as when partners’ misunderstandings or misperceptions of PrEP or sexual history and patterns either hindered or reinforced women participants’ attitudes and practices with PrEP.

Health systems level

Although study participants were uniquely positioned to understand, access and receive care and support about PrEP, they spoke of the health system barriers that impacted their peers’ and communities’ ability to safely access PrEP and the lack of provision, information and support provided by the government and large hospitals regarding PrEP. Previous studies have demonstrated that physical access to PrEP is correlated to PrEP uptake [33]. Though this did not affect participants in this study, physical access is likely a challenge for other members of the YWES community.

Pregnant or previously pregnant participants also expressed that pregnant YWES face healthcare stigma in Uganda and a lack of known support systems for pregnant, high-risk women. Most could not name an organization or community space other than the study clinic that provided care for pregnant YWES. Pregnancy rates are generally very high in Uganda and extremely high amongst the high-risk community in high-HIV burden regions, thus making the lack of support system and structures for this especially vulnerable population a critical gap for the overall health of young women and the elimination of mother-to-child transmission of HIV in Uganda [34].

Policy level

Pregnant or previously pregnant women in the study faced many of the same challenges as those who did not have pregnancy experience. However, a primary motivator of pregnant participants for declining, stopping, or waiting to initiate PrEP until after pregnancy, was the question of safety of PrEP during pregnancy. The World Health Organization (WHO) recommends offering PrEP to pregnant and breastfeeding women who are at a high risk for HIV acquisition [29]. Though much of PrEP-related literature does not report any adverse effects of PrEP on mother or child throughout pregnancy, this is a highly under-researched area [34, 35]. Due to the prioritization of fetal health, often times over maternal health, clinical research has historically excluded pregnant women from trials relating to PrEP safety. As a result, though many international policies do not exclude pregnant women from the population eligible for PrEP use, safety is still a large concern and the majority of studies call for more research. Uganda’s policy suggests PrEP for the HIV-negative partner in an HIV discordant couple and does not contraindicate PrEP during pregnancy or breastfeeding [14]. Most participants in this study who did not wish to initiate PrEP while pregnant or who stopped PrEP over the course of their pregnancy were worried about potential effects on their babies. Many stated they were taught at some point in their lifetimes that taking drugs while pregnant was not safe for the fetus. This fear is extremely important to consider as pregnancy and breastfeeding are critical times for HIV acquisition [29]. Most participants who were educated about the safety of taking PrEP while pregnant, when asked, recommended that high-risk women stay on PrEP throughout pregnancy. Thus, both additional research and educational interventions are necessary to appropriately address fears surrounding PrEP’s fetal effects. This study highlights that enhanced education for communities at high risk during reproductive age is critically important.

Recommendations for improvements in PrEP adherence can also be conceptualized within the multi-level barrier and facilitator framework. At the personal level, educational interventions could help YWES navigate changing life circumstances with regards to partners and pregnancy [30]. At the social level, targeting sexual and social networks is extremely important for interventions, along with education that targets YWES networks, especially their male partners who are socially positioned not only to alter their own behaviors with regards to PrEP but also to encourage PrEP use amongst their sexual partners [36]. Integrating wider social networks into HIV prevention and PrEP education could aid to reduce stigma [26]. At the health system level, access is of utmost concern. Ensuring affordable and widespread PrEP access at hospitals and clinics in Uganda, followed by community-oriented information and education on PrEP is likely to improve PrEP awareness. Alleviation of barriers such as distance or lack of transportation for YWES to obtain PrEP should be part of this effort. Communities must be offered PrEP in clinical spaces with educational tools available and robust advocacy. Moreover, national PrEP clinical guidelines with emphasis on PrEP safety during pregnancy are essential. Equally important is to address the grave consequences that stigmatizing and neglecting pregnant YWES carry in terms of these women’s and their babies’ health [35]. Lastly, though participants in this study did not speak of the criminalization of sex work in Uganda, this has profound implications for PrEP access and use at the policy level and for the eventual elimination of HIV in society.

This study contributes to important insights on PrEP adherence within specific high-risk communities in a sub-Saharan African social and cultural context. It is novel in that it includes the perspectives of pregnant women and how pregnancy plays an important role in using oral PrEP among a most vulnerable population. Future public health programming must tackle the perceptions and fears associated with taking any medication during pregnancy in order to be effective. Future studies must consider the importance of addressing the perspectives and the needs of the poorest of the poor in the words of late Paul Farmer in order to be able to truly control epidemics [37]. Mobilizing social services, the transactional sex and sex worker communities, and other community based organizing efforts can help fill gaps in research and interventions, blending medical, systemic, structural, and behavioral approaches.

Limitations

As the study included some non-pregnant women, perspectives offered by these participants, especially on questions of pregnancy, may not have been as representative of the pregnant high-risk population. For the objectives of this study, one could have selected participants from an ante-natal clinic and asked about high-risk sexual behavior. Perhaps, with that design, one would have accessed more pregnant women, but risked difficulty recruiting higher risk women. In an ante-natal clinic, one may have not had enough women able to discuss high risk sexual behavior. The study also relied on self-report to understand participant’s PrEP use. Thus, participants account of their PrEP use or willingness to disclose PrEP use may have resulted in some inaccurate information. However, the description of the diversity in PrEP use leads us to believe that there was likely very limited social desirability bias here. Another limitation is that the interviews were first analyzed by an English-speaking investigator, thus the process of data analysis in English may have resulted in the possibility of misinterpretation of words or ideas, as some participant perspectives may have been lost in translation. We did however, conduct two member-check sessions to assess our interpretations of results.

Conclusion

This study highlights the importance of addressing barriers to and facilitators of PrEP uptake and persistence in relation to pregnancy with a multi-level approach, incorporating personal, social, health systems and policy level factors. As noted, barriers to both uptake and adherence can be apparent on all levels. Though participants reported primarily on PrEP persistence as it related to their personal and social spheres, their views and experiences stressed the importance of systemic and policy interventions to promote the safe and effective use of PrEP. The acquisition of robust evidence about PrEP safety during pregnancy is of critical importance for the development of clear clinical guidelines and strategies for their implementation toward further control of HIV in the general population and the eventual elimination of mother-to-child transmission of HIV.

Supporting information

S1 File. PLOS questionnaire on inclusivity.

https://doi.org/10.1371/journal.pgph.0000434.s001

(PDF)

S2 File. ISSM COREQ checklist POPPi 27Oct22.

https://doi.org/10.1371/journal.pgph.0000434.s002

(PDF)

Acknowledgments

We are appreciative for the support of the community members in Kampala who generously gave their time to talk to us and we thank MRC/ UVRI and LSHTM Uganda Research Unit. We are particularly grateful to the POPPi team members for their work in keeping the projects alive through the COVID-19 pandemic. Thank you.

References

  1. 1. UNAIDS. Transactional sex and HIV risk: from analysis to action. Geneva: STRIVE; 2018.
  2. 2. Wamoyi J, Ranganathan M, Kyegombe N, Stoebenau K. Improving the Measurement of Transactional Sex in Sub-Saharan Africa: A Critical Review. J Acquir Immune Defic Syndr. 2019;80(4):367–74. pmid:30789453
  3. 3. Wamoyi J, Stobeanau K, Bobrova N, Abramsky T, Watts C. Transactional sex and risk for HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20992. pmid:27809960
  4. 4. UNAIDS. UNAIDS Data 2019. 2019.
  5. 5. Kharsany AB, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016;10:34–48. pmid:27347270
  6. 6. Tumwesige A dT L, Mwebaza E, Zalwango F, Nanyange J, Jjuuko A. Legal Regulation of Sex Work in Uganda: Exploring the Current Trends and their Impact on the Human Rights of Sex Workers. Kampala 2016 [www.hrapf.org.
  7. 7. Vithalani J, Herreros-Villanueva M. HIV Epidemiology in Uganda: survey based on age, gender, number of sexual partners and frequency of testing. Afr Health Sci. 2018;18(3):523–30. pmid:30602983
  8. 8. Goldenberg SM, Chettiar J, Simo A, Silverman JG, Strathdee SA, Montaner JS, et al. Early sex work initiation independently elevates odds of HIV infection and police arrest among adult sex workers in a Canadian setting. J Acquir Immune Defic Syndr. 2014;65(1):122–8. pmid:23982660
  9. 9. Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18(2 Suppl 1):19408. pmid:25724504
  10. 10. King R B, D, Nakitto M, Mirembe M, Seeley J. PrEP uptake and adherence among Young Female Sex Workers in Kampala, Uganda in POPPi; a Randomized Controlled Trial. INTEREST 2020; Namibia; virtual 20202020.
  11. 11. King R KF, Bagiire, D, Nakitto M, Mirembe M, Seeley J. PrEP uptake and adherence among Young Female Sex Workers in Kampala, Uganda in POPPi; a Randomized Controlled Trial. INTEREST 2020; Namibia; virtual2020.
  12. 12. Beckham SW, Shembilu CR, Brahmbhatt H, Winch PJ, Beyrer C, Kerrigan DL. Female sex workers’ experiences with intended pregnancy and antenatal care services in southern Tanzania. Stud Fam Plann. 2015;46(1):55–71. pmid:25753059
  13. 13. Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, et al. Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners. J Infect Dis. 2018;218(1):16–25. pmid:29514254
  14. 14. Davies N, Heffron R. Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. Sex Health. 2018;15(6):501–12. pmid:30447703
  15. 15. Heffron R, Pintye J, Matthews LT, Weber S, Mugo N. PrEP as Peri-conception HIV Prevention for Women and Men. Curr HIV/AIDS Rep. 2016;13(3):131–9. pmid:26993627
  16. 16. MOH. Consolidated Guidelines for Prevention and Treatment of HIV in Uganda. 2016.
  17. 17. Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–907. pmid:29937585
  18. 18. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. pmid:24047204
  19. 19. Ritchie J SL. Qualitative Data Analysis for Applied Policy Research. In: Huberman A MM, editor. The Qualitative Researcher’s Companion: SAGE Publications, Inc.; 2012. p. 305–29.
  20. 20. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. pmid:17872937
  21. 21. Benoit C, McCarthy B, Jansson M. Stigma, sex work, and substance use: a comparative analysis. Sociol Health Illn. 2015;37(3):437–51. pmid:25688450
  22. 22. Davey D, Mvududu R, Mashele N, Lesosky M, Khadka N, Bekker L, Gorbach P Coates T, Myer L. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa. JIAS. 2022;25(2).
  23. 23. Karim Q, Karim S, Soldan K, Zondi M. Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers. AJPH. 1995;85(11):1521–5. pmid:7485664
  24. 24. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;7(4):e249–e61. pmid:32087152
  25. 25. Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men. AIDS Behav. 2018;22(11):3566–75. pmid:29404756
  26. 26. Sidebottom D, Ekstrom AM, Stromdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV—how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581. pmid:30445925
  27. 27. Landovitz RJ, Li S, Eron JJ Jr., Grinsztejn B, Dawood H, Liu AY, et al. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. Lancet HIV. 2020;7(7):e472–e81. pmid:32497491
  28. 28. Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018;15(11):e1002690. pmid:30408115
  29. 29. Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? J Int AIDS Soc. 2020;23(1):e25426. pmid:31912985
  30. 30. Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, et al. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis. 2016;62(9):1172–7. pmid:26797207
  31. 31. Brooks RA, Cabral A, Nieto O, Fehrenbacher A, Landrian A. Experiences of Pre-Exposure Prophylaxis Stigma, Social Support, and Information Dissemination Among Black and Latina Transgender Women Who Are Using Pre-Exposure Prophylaxis. Transgend Health. 2019;4(1):188–96. pmid:31482134
  32. 32. Mehrotra ML, Rivet Amico K, McMahan V, Glidden DV, Defechereux P, Guanira JV, et al. The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men. AIDS Behav. 2018;22(11):3673–80. pmid:29754268
  33. 33. Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, et al. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study. AIDS Behav. 2020;24(7):2149–62. pmid:31955361
  34. 34. Pintye J, Beima-Sofie KM, Makabong OP, Njoroge A, Trinidad SB, Heffron RA, et al. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy. AIDS Patient Care STDS. 2018;32(12):538–44. pmid:30036072
  35. 35. Joseph Davey DL, Bekker LG, Gorbach PM, Coates TJ, Myer L. Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier. AIDS. 2017;31(16):2193–7. pmid:28723709
  36. 36. Macapagal K, Kraus A, Korpak AK, Jozsa K, Moskowitz DA. PrEP Awareness, Uptake, Barriers, and Correlates Among Adolescents Assigned Male at Birth Who Have Sex with Males in the U.S. Arch Sex Behav. 2020;49(1):113–24. pmid:31602584
  37. 37. Syvertsen JL, Robertson Bazzi AM, Scheibe A, Adebajo S, Strathdee SA, Wechsberg WM. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers. Afr J Reprod Health. 2014;18(3 Spec No):74–83. pmid:26050379